Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

NCT05014139 2025-11-20

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 1 Terminated

37 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT04057209 2025-10-07

VoiceS

Phase NA Recruiting

34 enrolled

Head & Neck

Carcinoma in Situ, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

NCT07189793 2025-09-24

OHAI-NMIBC-01

Phase 2 Not yet recruiting

106 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT07092007 2025-07-29

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

Phase NA Recruiting

18 enrolled

Gynecologic

Carcinoma in Situ, Uterine Cervical Neoplasms

NCT03223753 2025-04-18

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Phase 3 Active not recruiting

300 enrolled

Carcinoma in Situ

Clinical Trials

ADVANCED-3

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

BOND-003

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

ADVANCED-2

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

ON-5001

A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)

VoiceS

OHAI-NMIBC-01

NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer